Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ABB Ltd | ABJA | Mar 31, 2025 | 48.20 | -3.21 |
ABB LTD. CDR O.N. | ABJ3 | Mar 31, 2025 | 18.00 | 0.00 |
Abbott Laboratories | ABL | Mar 31, 2025 | 119.54 | -1.60 |
AbbVie Inc. | 4AB | Mar 31, 2025 | 194.04 | +2.29 |
ABC | EK7 | Mar 31, 2025 | 0.57 | +1.54 |
ABC Arbitrage | 9BA | Mar 31, 2025 | 5.65 | +0.36 |
ABC-Mart Inc. | 5B8 | Mar 31, 2025 | 17.00 | -1.16 |
AbCellera Biologics Inc. - | 8QQ | Mar 31, 2025 | 1.97 | -7.35 |
Abcourt Mines, Inc. | AML | Mar 31, 2025 | 0.03 | +3.33 |
ABEN MINERALS LTD | R26 | Mar 31, 2025 | 0.03 | 0.00 |
Abercrombie & Fitch Company | AFT | Mar 31, 2025 | 68.88 | -1.29 |
Aberdeen Asia-Pacificome Fund | 9J90 | Mar 31, 2025 | 13.96 | -0.21 |
Aberdeen International Inc | A8H | Mar 31, 2025 | 0.01 | 0.00 |
Aberdeen Standard European Logistics Income Plc | 5JX | Mar 31, 2025 | 0.66 | 0.00 |
Aberforth Smaller Companies Trust PLC | 0KJ | Mar 31, 2025 | 15.80 | -0.63 |
ABG Sundal Collier Holding | DAB | Mar 31, 2025 | 0.62 | +0.33 |
Abionyx Pharma | 609 | Mar 31, 2025 | 1.21 | -0.16 |
Abitare In Spa | 1BN | Mar 31, 2025 | 2.99 | -3.55 |
ABITIBI METALS CORP. | FW0 | Mar 31, 2025 | 0.18 | 0.00 |
Abivax | 2X1 | Mar 31, 2025 | 5.72 | -6.08 |
ABIVAX SA SP.ADR EO -,01 | 2X10 | Mar 31, 2025 | 5.55 | -5.93 |
ABL Group ASA | 26Q | Mar 31, 2025 | 0.80 | -1.24 |
Abliva | NTP | Mar 31, 2025 | 0.04 | 0.00 |
ABM Industries Incorporated | AB4 | Mar 31, 2025 | 43.60 | 0.00 |
ABM INVESTAMA TBK RP 100 | 0A1 | Mar 31, 2025 | 0.16 | 0.00 |
ABN AMRO Bank N.V. | AB2 | Mar 31, 2025 | 19.21 | -5.18 |
ABN AMRO BK.UNSP.ADR/1 | AB2A | Mar 31, 2025 | 19.00 | -3.55 |
ABO Wind AG | AB9 | Mar 31, 2025 | 36.90 | -8.21 |
ABO-Group | 3T61 | Mar 31, 2025 | 5.15 | +25.00 |
ABOUT YOU HLDG Z.VERK. | YOU0 | Mar 31, 2025 | 6.70 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.